Review timelines for generic drugs in the Philippines are set to be slashed dramatically, as part of efforts spearheaded by the country’s president to speed up new drug approvals and bring down medicines prices.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?